Established · publishing since 1993Rising activity
Chemokine receptors and signalingImmunotherapy and Immune ResponsesCancer Cells and Metastasis3D Printing in Biomedical Researchbioluminescence and chemiluminescence research
Publications
122
Citations
6,145
Est. group size
~9
Recurring co-author estimate
Active years
34
Publishing since 1993
In context
Among 4,953 established Medicine PIs within our index
Citations: 6,145p25 789 · p75 7,423 · cohort median 2,544
Publications / year (recent): 8.6p25 2 · p75 10.6 · cohort median 4.8
Typically publishes in teams of ~17 · 9% small-team papers (≤3 authors) · across 12 venues
Publication cadence
Publications per year over the last 10 years — averaging 8.6/year recently
Collaborators per year
Distinct co-authors at University of Michigan each year — a rough indication of whether the group around this researcher has been growing or contracting. An estimate from co-authorship, not a roster: collaborators are not necessarily lab members, and recent years can be under-counted while indexing catches up.
Recent publications
- Growth signaling autonomy in circulating tumor cells aids metastatic seeding
PNAS Nexus · 2024
- Molecular insights into intrinsic transducer-coupling bias in the CXCR4-CXCR7 system
Nature Communications · 2023
- Microfluidic single-cell migration chip reveals insights into the impact of extracellular matrices on cell movement
Lab on a Chip · 2023
- Regulation of DNA damage response by trimeric G-proteins
iScience · 2023
- High‐Throughput Cellular Heterogeneity Analysis in Cell Migration at the Single‐Cell Level (Small 6/2023)
Small · 2023
- Data from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023
- Supplemental Figure 6 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023
- Supplemental Figure 5 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023
- Supplemental Table 1-3 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023
- Supplemental Figure 4 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023
- Supplemental Figure 1-2 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023
- Supplemental Figure 7 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023
- Supplemental Figure 3 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023
- Supplemental Figure 4 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023
- Supplemental Figure 6 from CXCR4 Protein Epitope Mimetic Antagonist POL5551 Disrupts Metastasis and Enhances Chemotherapy Effect in Triple-Negative Breast Cancer
2023
Publishes in
- bioRxiv (Cold Spring Harbor Laboratory)×6
- Cancer Research×3
- Acta Biomaterialia×2
- Nature Communications×2
- Small×2
Similar researchers
By research-topic overlap
- Paramita Ray
Medicine · University of Michigan
- Joshua J. Ziarek
Medicine · Indiana University
- Amy Gursky
Medicine · University of Michigan
- Scott Cooper
Medicine · Indiana University
- Gary D. Luker
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile